(AUSTIN) — The Cancer Prevention and Research Institute of Texas (CPRIT) announced 74 new cancer research and prevention grants totaling over $112,768,740. The projects approved today include 65 academic research grant awards, seven prevention
awards, and two product development research awards granted to 16 institutions and companies across the state. These awards will expand access to clinical trials, incubate innovative cancer research, support the state’s emerging biotechnology
industry, provide needed cancer screenings for underserved Texans and recruit outstanding cancer researchers to Texas.
“The grants awarded today illustrate the broad spectrum of CPRIT’s impact in the fight against cancer,” explained Wayne Roberts, CPRIT’s Chief Executive Officer. “From recruitment awards bringing topflight researchers to
Texas, continued investment in cancer prevention and screening programs across the state and supporting cancer-fighting innovation in early-stage companies, Texas just took another major step forward in becoming a national leader in conquering cancer.”
CPRIT has also recently released its 2021 Annual Report. The 2021 Annual Report highlights the eleventh – and exceptional -- year of cancer research and prevention awards made in service of CPRIT’s historical three-part mission to invest
in Texas’ research prowess, create and expand life science infrastructure across the state, and expedite innovation in cancer research and prevention strategies.
The 2021 Annual Report can be viewed here: https://2021annualreport.cprit.texas.gov/
To date, CPRIT has awarded $3.0 billion in grants to Texas research institutions and organizations through its academic research, prevention and product development research programs. CPRIT has recruited 263 distinguished researchers, supported the establishment,
expansion or relocation of 44 companies to Texas and generated over $7.5 billion in additional public and private investment.
CPRIT funding has advanced scientific and clinical knowledge and provided 7.8 million life-saving cancer prevention and early detection services reaching Texans from all 254 counties. On November 5, 2019, Texas voters overwhelmingly approved a constitutional
amendment to provide an additional $3 billion to CPRIT for a total $6 billion investment in cancer research and prevention.
Learn more at https://cprit.texas.gov/.
Individual Investigator Research Awards for Prevention and Early Detection
The University of Texas Medical Branch at Galveston
- RP220011 A Randomized, Controlled Trial Comparing the Immunogenicity of 2 doses vs 3 doses of the 9-Valent HPV Vaccine in Females 27 to 45 Years of Age (Berenson, Abbey) $1,986,984